Long-term PPI use linked to pneumonia risk in older adults

Long-term PPI use linked to pneumonia risk in older adults

(HealthDay)—Among older adults in primary care, use of proton pump inhibitors (PPIs) is associated with greater risk of pneumonia in the second year of treatment, according to a study published in the July issue of the Journal of the American Geriatrics Society.

Jan Zirk-Sadowski, Ph.D., from the University of Exeter in the United Kingdom, and colleagues assessed associations between long-term use of PPIs and pneumonia incidence. The analysis included 75,050 (≥60 years) who were in and had been receiving PPIs for at least one year and 75,050 age- and sex-matched controls.

The researchers found that during the second year after initiating treatment, PPIs were associated with greater hazard of incident pneumonia (prior event rate ratio-adjusted hazard ratio, 1.82), accounting for pretreatment pneumonia rates. Across age and comorbidity subgroups, estimates were similar.

"Controversies about the validity of reported short-term harms of PPIs should not divert attention from potential long-term effects of PPI prescriptions on older adults," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further

Commonly prescribed heartburn drug linked to pneumonia in older adults

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: Long-term PPI use linked to pneumonia risk in older adults (2018, August 23) retrieved 24 June 2021 from https://medicalxpress.com/news/2018-08-long-term-ppi-linked-pneumonia-older.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments